SEGMENT INFORMATION- Schedule of Disaggregation of Total Net Product Revenues by Geographic Region (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Disaggregation of Revenue [Line Items]
Total revenues	$ 2,853,915	$ 2,419,226	$ 2,096,039
ALDURAZYME
Disaggregation of Revenue [Line Items]
Total revenues	183,887	131,248	128,422
Product
Disaggregation of Revenue [Line Items]
Total revenues	2,809,445	2,372,538	2,042,025
Marketed by Company | Products excluding ALDURAZYME
Disaggregation of Revenue [Line Items]
Total revenues	2,625,558	2,241,290	1,913,603
Marketed by Company | Products excluding ALDURAZYME | United States
Disaggregation of Revenue [Line Items]
Total revenues	924,810	771,314	684,284
Marketed by Company | Products excluding ALDURAZYME | Europe
Disaggregation of Revenue [Line Items]
Total revenues	829,031	669,331	650,952
Marketed by Company | Products excluding ALDURAZYME | Latin America
Disaggregation of Revenue [Line Items]
Total revenues	378,084	332,437	266,801
Marketed by Company | Products excluding ALDURAZYME | Rest of world
Disaggregation of Revenue [Line Items]
Total revenues	493,633	468,208	311,566
Marketed by Sanofi | ALDURAZYME
Disaggregation of Revenue [Line Items]
Total revenues	$ 183,887	$ 131,248	$ 128,422